Samples positive for HBV DNA were quantified by TaqMan real-time PCR technology, as previously described [25], using the probe, 5’-FAM-TGTTGACAARAATCCTCACAATACCRCAGA-TAMRA-3´ (nt 218-247). The assay has a limit of detection of 10 eFT-508 clinical trial copies/reaction (i.e., 100 copies/mL serum). Categorical variables were compared using Fisher’s exact tests, and

differences between continuous variables were assessed using Student’s t-tests. Differences were considered statistically significant for P-values < 0.05. Statistical SC79 mw analyses were performed using SPSS version 17 (SPSS, Chicago, IL, USA). Primer design and PCR assays for pyrosequencing Pyrosequencing was performed using PyroMark Q96 ID (QIAGEN Valencia, PF-6463922 chemical structure CA, USA). This instrument offers quantitative SNPs and mutation analysis by rapidly sequencing short stretches of DNA directly from PCR templates.

PCR amplification and pyrosequencing primers were designed using PyroMark Assay Design 2.0 software. The following primers were designed to amplify a 218-bp fragment of the HBV rt polymerase domain containing the YMDD motif: forward primer, 5’-TTGCACCTGTATTCCCAT-3’ (nt 594-611); reverse primer, 5’-AAAATTGGTAACAGCGGTAWA AA-3’ (nt 791-812). The forward primer was 5’ biotin-labeled to enable preparation of a single-stranded template for pyrosequencing. The sequencing primer (5’-GTTTGGCTT TCAGYTAT-3’; nt 724-736) was located immediately upstream of codon rt204. DNA was amplified using 5 U/μL Platinum cAMP inhibitor Taq DNA polymerase High Fidelity (Invitrogen), 10 mM dNTPs, 10X PCR buffer, 50 mM MgCl2 and 10 μM primer mix in a final volume of 50

μL under the following thermocycling conditions: initial denaturation at 94°C for 3 min, then 30 cycles of 94°C for 30 s, 55°C for 30 s and 68°C for 30 s, followed by a final elongation step (5 min at 68°C). Biotinylated PCR products were hybridized to streptavidin-coated beads and purified using the PyroMark Q96 Vacuum Prep Workstation (Qiagen, Valencia, CA, USA) according to the manufacturer’s instructions. Sequencing primers were annealed by incubating at 80°C for 2 min. Pyrosequencing reactions were performed using the PyroMark Gold Q96 SQA Reagents in the PyroMark Q96 ID (QIAGEN). The dispensation order algorithm for pyrosequencing was CAGTACGCATG. Data collection and quantification analyses were performed using PyroMark ID software. Mixtures of plasmids carrying wild-type (WT) and YVDD-resistant (MUT) sequences were prepared to evaluate the ability of the pyrosequencing method to accurately detect and quantify minor sequence variants. Mixtures ranging from 100% WT-0% MUT to 0% WT-100% MUT were prepared at increments of 10% of each plasmid. A mixture of 95%-5% of each plasmid was tested to assess the sensitivity of the pyrosequencing assay in detecting minor subpopulations as low as 5% of the total.